Instrument Inactif

Communiqués Progenics Pharmaceuticals, Inc.

Actions

US7431871067

Recherche biotechnologique et médicale

Communiqués

22/06/20	PROGENICS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
22/06/20	Progenics Pharmaceuticals : Lantheus Completes Merger with Progenics	BU
17/06/20	PROGENICS PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
16/06/20	PROGENICS PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
16/06/20	Progenics Stockholders Approve Merger with Lantheus	GL
11/06/20	PROGENICS PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)	AQ
08/06/20	PROGENICS PHARMACEUTICALS INC : Other Events (form 8-K)	AQ
28/05/20	PROGENICS PHARMACEUTICALS INC : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	AQ
28/05/20	WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.	PR
19/05/20	Progenics Pharmaceuticals : to Present Results from the Phase 3 CONDOR Trial of PyL in Prostate Cancer at the American Society of Clinical Oncology 2020 Virtual Scientific Program	AQ
18/05/20	PROGENICS PHARMACEUTICALS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
18/05/20	Progenics to Present Results from the Phase 3 CONDOR Trial of PyL™ (18F-DCFPyL) in Prostate Cancer at the American Society of Clinical Oncology 2020 Virtual Scientific Program	GL
08/05/20	Progenics Class Action: Halper Sadeh LLP Announces Filing Of Shareholder Class Action Lawsuit Against Progenics Pharmaceuticals, Inc.; Investors Are Encouraged To Contact The Firm	PR
07/05/20	PROGENICS PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
07/05/20	Progenics: 1Q Earnings Snapshot	AQ
07/05/20	PROGENICS PHARMACEUTICALS INC : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
07/05/20	Progenics Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update	GL
24/04/20	Faruqi & Faruqi, LLP : Announces Filing of a Class Action Lawsuit Against Progenics Pharmaceuticals, Inc. (PGNX)	PR
23/04/20	Progenics Pharmaceuticals Sets First Quarter 2020 Financial Results and Business Update Call for May 7	GL
14/04/20	PROGENICS PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
14/04/20	Progenics Pharmaceuticals : ADDING MULTIMEDIA Velan Capital Agrees to Support Merger of Lantheus and Progenics	BU
02/04/20	PROGENICS PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
01/04/20	PROGENICS PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)	AQ
16/03/20	PROGENICS PHARMACEUTICALS : ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS	AQ
16/03/20	PROGENICS PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ